2026 Wilson Disease Association CME Conference

Saturday, September 26, 2026, 8:00 AM - 3:30 PM, Northwestern Memorial Hospital, Chicago, IL

This CME conference provides a comprehensive, multidisciplinary educational update on Wilson disease, a rare but treatable disorder that is frequently underdiagnosed and mismanaged in clinical practice. Despite advances in understanding copper metabolism and disease phenotypes, clinicians across hepatology, neurology, psychiatry, genetics, and primary care continue to face challenges related to delayed diagnosis, recognition of atypical and extrahepatic presentations, and uncertainty regarding optimal treatment selection and long-term monitoring. Rapidly evolving diagnostic tools and emerging therapies further underscore the need for timely, evidence-based education.

1. Apply a systematic diagnostic approach to Wilson disease using clinical, biochemical, and genetic tools.
2. Select and monitor chelation and zinc therapies based on disease phenotype, stage, and patient factors.
3. Manage neurologic and psychiatric manifestations with pharmacotherapy, botulinum toxin, and rehabilitation.
4. Determine indications for liver transplant and implement hepatic surveillance protocols.
5. Evaluate emerging therapies including novel chelators, gene therapy, and gene editing approaches.
6. Implement multidisciplinary care for special populations including pediatric transition, pregnancy, and extrahepatic complications.

Click the "Register" tab above to complete your registration online by September 25, 2026. Payment may be made by credit card or check. If paying by check, please mail your check, made payable to Northwestern Memorial Hospital (CME), to the address listed below prior to Wednesday, September 9, 2026:

Tiffany McReynolds
c/o Northwestern Memorial HealthCare
541 N. Fairbanks Court, Suite 950
Chicago, IL 60611

Registration and breakfast will begin at 7:30 a.m.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Northwestern University Feinberg School of Medicine and Wilson's Disease Association. The Northwestern University Feinberg School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (6.25 hours), Non-Physician Attendance (6.25 hours)

Mitigation of Relevant Financial Relationships

Feinberg School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a Continuing Education activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.